Juvenile Idiopathic Arthritis

Status of Juvenile Idiopathic Arthritis Guideline

Guidelines

2021 JIA Guidelines

JIA Oligoarthritis, TMJ, and sJIA
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Documents related to the 2021 JIA oligoarthritis, TMJ, and sJIA guideline:

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

Documents related to the 2021 JIA nonpharmacologic, medication monitoring, immunizations, and imaging guideline:


2019 JIA Guidelines

JIA
American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis - 2019

Documents related to the 2019 JIA guideline:

JIA Uveitis
American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis - 2019

Documents related to the 2019 JIA uveitis guideline:

arthritis-foundation-logo


2013 JIA Guideline

2013 Update of 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis

Documents related to the 2013 JIA guideline:


2011 JIA Guideline

American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis - 2011

Clinician Guide - 2011

© 2022 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us